Losartan/hctz 50/12.5mg Tablets

Manufacturer AUROBINDO Active Ingredient Losartan and Hydrochlorothiazide(loe SAR tan & hye droe klor oh THYE a zide) Pronunciation loe SAR tan & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.It is used to lower the chance of stroke in people with high blood pressure and a heart problem called left ventricular hypertrophy. This drug may not help lower the chance of stroke in Black patients with these health problems.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) and Thiazide Diuretic Combination
🤰
Pregnancy Category
Contraindicated (2nd and 3rd Trimesters); Avoid (1st Trimester)
✅
FDA Approved
Apr 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Losartan/HCTZ is a combination medicine used to treat high blood pressure. Losartan helps relax blood vessels, and hydrochlorothiazide is a 'water pill' that helps your body get rid of extra salt and water. Together, they help lower your blood pressure, which can reduce your risk of heart attack and stroke.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely. You can take this medication with or without food. Continue taking the medication as directed by your doctor or healthcare provider, even if you start to feel better.

It's common for this medication to increase urine production. To minimize sleep disturbances, try to avoid taking it too close to bedtime. Unless your doctor advises you to limit fluid intake, drink plenty of non-caffeinated liquids to stay hydrated.

Storing and Disposing of Your Medication

To maintain the medication's effectiveness, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep the container tightly closed and store all medications in a safe location, out of the reach of children and pets.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Limit alcohol intake as it can further lower blood pressure.
  • Avoid potassium supplements or salt substitutes containing potassium unless advised by your doctor.
  • Maintain a healthy diet low in sodium and saturated fats.
  • Engage in regular physical activity as recommended by your doctor.
  • Monitor your blood pressure regularly at home if advised by your doctor.
  • Stay well-hydrated, especially in hot weather or during exercise, to prevent dehydration.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 50 mg losartan/12.5 mg hydrochlorothiazide orally once daily
Dose Range: 50 - 100 mg

Condition-Specific Dosing:

hypertension: Initial dose is typically 50/12.5 mg once daily. May be increased to 100/25 mg once daily if blood pressure is not adequately controlled after 3 weeks of therapy.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and effectiveness not established in pediatric patients <18 years of age)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed (CrCl >50 mL/min)
Moderate: No dosage adjustment needed (CrCl 30-50 mL/min), but monitor closely.
Severe: Not recommended (CrCl <30 mL/min) due to hydrochlorothiazide component.
Dialysis: Not recommended. Losartan is not dialyzable. Hydrochlorothiazide is dialyzable but its use is contraindicated in anuric patients.

Hepatic Impairment:

Mild: Use with caution. Losartan dose reduction may be considered for severe hepatic impairment if using losartan alone, but combination product is generally not recommended for severe impairment.
Moderate: Use with caution. Not recommended for severe hepatic impairment.
Severe: Not recommended.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Losartan: An angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues (e.g., vascular smooth muscle, adrenal gland). This prevents the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation, decreased aldosterone secretion, and reduced sodium and water reabsorption. Hydrochlorothiazide: A thiazide diuretic that inhibits the reabsorption of sodium and chloride ions in the distal convoluted tubule of the nephron. This increases the excretion of sodium, chloride, and water, leading to a reduction in plasma volume and blood pressure. It also increases potassium and magnesium excretion and decreases calcium excretion.
📊

Pharmacokinetics

Absorption:

Bioavailability: Losartan: ~33%; Hydrochlorothiazide: 65-75%
Tmax: Losartan: 1 hour (losartan), 3-4 hours (active metabolite E-3174); Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Losartan: Decreases Cmax and slightly decreases AUC; Hydrochlorothiazide: Increases absorption slightly.

Distribution:

Vd: Losartan: 34 L; Hydrochlorothiazide: 0.8-1.7 L/kg
ProteinBinding: Losartan: >98%; Hydrochlorothiazide: 40-60%
CnssPenetration: Limited for both

Elimination:

HalfLife: Losartan: 2 hours; E-3174: 6-9 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Not available
ExcretionRoute: Losartan: Biliary (60%), Renal (35%); Hydrochlorothiazide: Renal (primarily unchanged)
Unchanged: Losartan: ~4%; E-3174: ~6%; Hydrochlorothiazide: >95%
âąī¸

Pharmacodynamics

OnsetOfAction: Losartan: 1 hour; Hydrochlorothiazide: 2 hours
PeakEffect: Losartan: 6 hours; Hydrochlorothiazide: 4 hours
DurationOfAction: Losartan: 24 hours; Hydrochlorothiazide: 6-12 hours
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Losartan/HCTZ as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of kidney problems, such as:
+ Unable to pass urine
+ Change in how much urine is passed
+ Blood in the urine
+ Significant weight gain
Signs of fluid and electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or change in the amount of urine produced
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or vomiting
Signs of a pancreas problem (pancreatitis), such as:
+ Severe stomach pain
+ Severe back pain
+ Severe upset stomach or vomiting
Severe dizziness or passing out
Swelling in the arms or legs
Yellow skin or eyes
Difficulty getting or maintaining an erection

This medication can also cause eye problems, which may lead to permanent vision loss if left untreated. If you experience any of the following symptoms, contact your doctor right away:
Changes in vision
Eye pain

These symptoms usually occur within hours to weeks of starting the medication.

Rare but Serious Side Effects

Rarely, people taking hydrochlorothiazide have developed certain types of skin cancer. To minimize your risk:
Protect your skin from the sun
Follow your doctor's instructions for skin checks
Contact your doctor immediately if you notice:
+ Changes in the color or size of a mole
+ New or changing skin lumps or growths

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people experience no side effects or only mild ones, some may be bothered by:
Dizziness
Signs of a common cold
Back pain

If you experience any of these side effects or any other symptoms that concern you, contact your doctor for advice.

Reporting Side Effects

If you have questions or concerns about side effects, you can:
Contact your doctor
Call the FDA at 1-800-332-1088
Report side effects online at https://www.fda.gov/medwatch
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting
  • Unusual tiredness or weakness
  • Muscle cramps or pain
  • Irregular heartbeat
  • Signs of dehydration (e.g., extreme thirst, dry mouth, decreased urination)
  • Swelling of the face, lips, tongue, or throat (signs of allergic reaction)
  • Difficulty breathing or swallowing
  • Yellowing of the skin or eyes (jaundice)
  • Dark urine
  • Persistent nausea or vomiting
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
A known sulfa allergy.
Current or planned use of dofetilide.
Difficulty urinating.
Dehydration; if you are dehydrated, discuss this with your doctor.
Use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.

This list is not exhaustive, and it is crucial to disclose all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues to your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, avoid driving and other activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position and exercise caution when climbing stairs.

If you have diabetes, closely monitor your blood sugar levels. Additionally, check your blood pressure as directed by your healthcare provider and undergo blood tests as scheduled. Be aware that this medication may interfere with certain laboratory tests, so inform all your healthcare providers and laboratory personnel that you are taking this drug.

If you are using a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Similarly, if you are on a low-sodium or sodium-free diet, discuss this with your doctor.

Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult your doctor. Also, discuss the use of alcohol, marijuana or other cannabis products, or prescription and OTC drugs that may cause drowsiness with your doctor.

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, which may lead to low blood pressure, inform your doctor promptly.

If you are taking cholestyramine or colestipol, consult your pharmacist about the proper administration of these medications with this drug. Be aware of the potential for gout attacks.

This medication may cause elevated cholesterol and triglyceride levels; discuss this with your doctor. If you have lupus, this medication can exacerbate the condition; immediately report any new or worsening symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, consult your doctor to discuss potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (low blood pressure)
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Dehydration
  • Electrolyte imbalance (e.g., hypokalemia, hyponatremia)
  • Dizziness
  • Fainting

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic, including intravenous fluids for hypotension and correction of electrolyte imbalances.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • Lithium (increased serum lithium levels and toxicity)
  • NSAIDs (including COX-2 inhibitors - may reduce diuretic, natriuretic, and antihypertensive effects; may worsen renal function)
  • ACE inhibitors (increased risk of hyperkalemia, hypotension, renal impairment with dual blockade)
  • Other antihypertensive agents (additive hypotensive effect)
  • Corticosteroids, ACTH (intensified electrolyte depletion, particularly hypokalemia)
  • Cholestyramine, Colestipol resins (impaired absorption of hydrochlorothiazide)
🟡

Moderate Interactions

  • Alcohol, barbiturates, narcotics (orthostatic hypotension)
  • Antidiabetic drugs (oral agents and insulin - may require dosage adjustment due to HCTZ effect on glucose)
  • Digitalis glycosides (hypokalemia/hypomagnesemia may predispose to digitalis toxicity)
  • Muscle relaxants, non-depolarizing (enhanced effect)
  • Pressor amines (e.g., norepinephrine - decreased arterial responsiveness)
  • Allopurinol (increased risk of hypersensitivity reactions with HCTZ)
  • Calcium salts (increased serum calcium levels with HCTZ)
  • Cyclosporine (increased risk of hyperuricemia and gout with HCTZ)
  • Diazoxide (hyperglycemic and hypotensive effects)
đŸŸĸ

Minor Interactions

  • Not available (interactions are generally categorized as major or moderate due to clinical significance)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy.

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte balance, especially potassium due to ARB/diuretic effects.

Timing: Prior to initiation

Renal Function (BUN, Serum Creatinine, eGFR)

Rationale: To assess baseline kidney function, crucial for dosing and monitoring for ARB/diuretic effects.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: Losartan is metabolized by the liver; to assess baseline hepatic function.

Timing: Prior to initiation

Serum Uric Acid

Rationale: Hydrochlorothiazide can increase uric acid levels.

Timing: Prior to initiation

Blood Glucose

Rationale: Hydrochlorothiazide can affect glucose metabolism.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly after initiation/dose change, then monthly/quarterly

Target: <130/80 mmHg (or individualized target)

Action Threshold: Persistent elevation above target, or symptomatic hypotension

Serum Electrolytes (Potassium, Sodium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 or >150 mEq/L; symptomatic electrolyte imbalance

Renal Function (BUN, Serum Creatinine, eGFR)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Stable eGFR, BUN/Cr within normal limits or baseline

Action Threshold: Significant increase in creatinine (>30% from baseline), or eGFR decline, especially if symptomatic

Serum Uric Acid

Frequency: Annually or as clinically indicated, especially if history of gout

Target: Within normal limits

Action Threshold: Symptomatic hyperuricemia or gout flares

Blood Glucose

Frequency: Annually or as clinically indicated, especially in diabetic patients

Target: Individualized for diabetic patients

Action Threshold: Significant hyperglycemia

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fainting (especially upon standing)
  • Fatigue
  • Muscle cramps or weakness
  • Nausea
  • Vomiting
  • Excessive thirst
  • Dry mouth
  • Swelling in ankles or feet (rare, but monitor for fluid retention if BP not controlled)
  • Signs of hyperkalemia (e.g., irregular heartbeat, muscle weakness)
  • Signs of hypokalemia (e.g., muscle cramps, weakness, irregular heartbeat)

Special Patient Groups

🤰

Pregnancy

Contraindicated in the second and third trimesters of pregnancy due to significant risk of fetal injury and death. Avoid use in the first trimester as well.

Trimester-Specific Risks:

First Trimester: Limited human data, but animal data suggest potential risk. Generally avoided due to class effect of ARBs.
Second Trimester: High risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
Third Trimester: High risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death. Neonatal hypotension, hyperkalemia, and anuria may occur.
🤱

Lactation

Not recommended during breastfeeding. Both losartan and hydrochlorothiazide are excreted in breast milk. Losartan has no human data, but animal data show excretion. Hydrochlorothiazide can decrease milk supply, especially in early postpartum.

Infant Risk: Potential for adverse effects in the infant (e.g., hypotension, electrolyte imbalance). Risk of decreased milk supply for the mother.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients under 18 years of age. Not recommended for routine use.

👴

Geriatric Use

No specific dosage adjustment is generally required based on age alone. However, elderly patients may be more sensitive to the effects of the drug, particularly volume depletion and renal impairment. Monitor renal function and electrolytes closely.

Clinical Information

💎

Clinical Pearls

  • Losartan/HCTZ is a first-line option for hypertension, especially when a single agent is insufficient or when a diuretic is indicated.
  • The combination product simplifies dosing and may improve adherence compared to taking two separate pills.
  • Monitor for orthostatic hypotension, especially at initiation or dose escalation, and advise patients to rise slowly.
  • Educate patients about the importance of avoiding potassium supplements or salt substitutes unless specifically instructed by their physician.
  • Regular monitoring of renal function and electrolytes (especially potassium and sodium) is crucial, particularly in patients with pre-existing renal impairment, heart failure, or those on concomitant medications that affect electrolytes.
  • Due to the black box warning, ensure female patients of childbearing potential are aware of the fetal toxicity risk and use effective contraception. Discontinue immediately if pregnancy is detected.
🔄

Alternative Therapies

  • ACE inhibitors (e.g., Lisinopril, Enalapril)
  • Calcium Channel Blockers (e.g., Amlodipine, Nifedipine)
  • Beta-blockers (e.g., Metoprolol, Carvedilol)
  • Other diuretics (e.g., Chlorthalidone, Indapamide, Furosemide)
  • Direct Renin Inhibitors (e.g., Aliskiren - generally not recommended with ARBs)
💰

Cost & Coverage

Average Cost: Varies, typically $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic) or Tier 2 (Preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.